Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Accelerated vs Iontophoresis Cross-linking for Keratoconus
NCT03429569Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Aug 2015
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of riboflavin in keratoconus, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT03429569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03429569.